≡

Multiplex Assay Kit for Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array)

VEGF-B; VEGFL; VRF; VEGF-Related Factor

Specificity

This assay has high sensitivity and excellent specificity for detection of Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-105 101
EDTA plasma(n=5) 87-102 92
heparin plasma(n=5) 86-93 90

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-103% 98-105% 81-98% 86-93%
EDTA plasma(n=5) 80-104% 97-105% 89-103% 83-96%
heparin plasma(n=5) 81-90% 80-90% 80-93% 87-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Cardiology Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. PubMed: 22459379
Applied Sciences-Basel Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study pubmed:29099033
Journal of Endocrinological Investigation Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell 10.1007/s40618-017-0677-z
EXCLI Journal Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction
Cancer Chemother Pharmacol Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors 34164713
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA144Ra01 Recombinant Vascular Endothelial Growth Factor B (VEGFB) Positive Control; Immunogen; SDS-PAGE; WB.
PAA144Ra01 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB) Testing in progress
SEA144Ra ELISA Kit for Vascular Endothelial Growth Factor B (VEGFB) Enzyme-linked immunosorbent assay for Antigen Detection.
CMA144Ra Multiplex Assay Kit for Vascular Endothelial Growth Factor B (VEGFB) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMA144Ra Multiplex Assay Kit for Vascular Endothelial Growth Factor B (VEGFB) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.